Recently, it was reported that the presence of mutant alleles in the promoter region (−221 C>G) of the MBL2 gene could protect against the more severe forms of the liver injury (cirrhosis and HCC) [21], and a better liver function was shown as associated with high MBL serum levels [22]. This evidence concerns the gene MBL2 and hepatocellular carcinoma.